Pharmacology Alirocumab and Evolocumab are: A NPGL1 inhibitors B Microsomal transport protein inhibitors C PCSK - 9 inhibitors D Lipoprotein lipase inhibitors π‘ Explanation Alirocumab and Evolocumab are: β Correct Answer: C. PCSK - 9 inhibitors